Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNERGY: Enoxaparin vs UFH in ACS
NCT00043784Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2001
- Primary completion
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in acute coronary syndrome (ACS), unstable angina, myocardial infarction (MI), sponsored by Sanofi. Started Aug 2001; status: completed.
02
Drugs
enoxaparin
03
Conditions
acute coronary syndrome (ACS)unstable anginamyocardial infarction (MI)
Beyond the preview
Go deeper on NCT00043784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043784.